ROXALL Group

Pharmaceutical Manufacturing • Oststeinbek, Schleswig-Holstein, Germany • 101-200 Employees

Company overview

Headquarters	Meessen 20, Oststeinbek, 22113, DE
Phone number	+49408972520
Website	roxall.com
NAICS	3254
SIC	283
Keywords	Spezifische Immuntherapie And Allergology
Employees	101-200
Socials

Key Contacts at ROXALL Group

Javier Escoriaza Jiménez

Director Industrial

Javier Escoriaza

Industrial Director

Eduardo Cue

Commercial Director

Olaf Putensen

Medical Management Director

Fernanda Olavarria Ros

Regulatory Affairs & Quality Director In Roxall Medizin Spain

ROXALL Group Email Formats

ROXALL Group uses 3 email formats. The most common is {first name}.{last name} (e.g., john.doe@roxall.pt), used 71.4% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@roxall.pt	85.7%
{first name}{last name}	johndoe@roxall.de	14.3%

About ROXALL Group

ROXALL Group is an international pharmaceutical company based in Hamburg, Germany. Our core business is pharmaceuticals for allergen immunotherapy – the only causal allergy therapy renowned by the World Health Organization (WHO) that not only has the capacity to prevent an allergy turning into asthma but can also block the growth of new sensitizations. At ROXALL, we strive to constantly improve our treatments and to manufacture the highest quality products. As a result, we have made several and many of the most important innovations in this field. ROXALL Group has subsidiaries in Europe, Asia and Latin America. The acquisition of the allergy-line of a pharmaceutical company in Bilbao, Spain, opened us a solid basis for future growth. Research in immuno- therapy has been the main focus of this company for more than 70 years. Our team in Bilbao works closely with leading research institutes, providing us with greater potential for developing new treatments. In addition to our allergen immune therapies, our subsidiary company DR. BECKMANN Pharma offers medical products that help ease many allergy symptoms. Our products range from nasal showers and ointments for sensitive skin to high quality allergen encasings and peak-flow meters.

ROXALL Group revenue & valuation

Annual revenue	$3,500,000
Revenue per employee	$32,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$11,200,000
Total funding	No funding